3860 results for «373»

Filter By

3860 results

Left main and complex bifurcation stenting

14 May 2024 – From EuroPCR 2024

Watch this session focused on a patient with distal left main stenosis to understand that the stepwise provisional side branch (SB) stenting strategy is the standard approach for most left main trifurcation lesions. Discover the importance of optical frequency domain imaging for strategy determination and bifurcation...

Left main and complex bifurcation stenting

Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options

15 May 2024 – From EuroPCR 2024

In this session, uncover new data on Murray-law based quantitative flow ratio (muFR) assessment, providing a comprehensive understanding of PCI outcomes from a single angiographic view, explore the innovative application of artificial intelligence in identifying vulnerable plaque and assessing hemodynamic stenosis significance through the analysis of...

Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options

From innovation to reality: the impact of Cre8 EVO technology on complex PCI

15 May 2024 – From EuroPCR 2024

This session is a good opportunity to delve into the contemporary technical and clinical complexities surrounding complex PCIs in challenging patient cases. Explore the necessary tools and treatment strategies to enhance peri-procedural and long-term clinical outcomes, and follow discussions on the unique technologies of Cre8 EVO...

From innovation to reality: the impact of Cre8 EVO technology on complex PCI

Complex PCI in ACS patient with high bleeding risk: optimise the strategy

15 May 2024 – From EuroPCR 2024

Watch this session for insights into managing acute coronary syndrome patients with multivessel disease, updates on treatment approaches, comparing FULL RESVAC with previous trials like COMPLETE or FIRE, for example, and information on ongoing trials such as FRAMI-AMI 2 and 3. Explore the LIVE case presentation...

Complex PCI in ACS patient with high bleeding risk: optimise the strategy

LANDMARK RCT - Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

15 May 2024 – From EuroPCR 2024

This session provides an overview of the early outcomes of the LANDMARK trial, a randomized non-inferiority trial comparing TAVI devices. It examines baseline characteristics, the significance of intermediate sizes according to MSCT recommendations, real-world representative cases from the LANDMARK RCT, insights from quantitative aortography and echocardiography...

LANDMARK RCT - Early

The future of STEMI care: a new treatment for bridging the gap from diagnosis to treatment

14 May 2024 – From EuroPCR 2024

Watch this session to delve into the crucial role of pre-hospital STEMI diagnosis and treatment. Gain insights into the significance of early intervention and explore previous facilitated PCI trials in STEMI. Additionally, learn about a promising new agent for pre-hospital STEMI treatment, offering potential advancements in...

The future of STEMI care: a new treatment for bridging the gap from diagnosis to treatment

Valve-in-Valve

17 Feb 2024 – From PCR Tokyo Valves 2024

Discover various compelling cases of valve-in-valve interventions in this session: such as TAVI for a structural valve deterioration with winding snake-like aorta, the uses of tomography-fluoroscopy fusion imaging in bioprosthetic aortic valve cracking, and more!

TAVI for patients with concomitant coronary artery disease - LIVE case

17 Feb 2024 – From PCR Tokyo Valves 2024

An 88-year-old male presented a severe symptomatic aortic valve with preserved LV function (64%), a coronary artery disease with a LAD PCI a few years ago and a significant (75%) RCA stenosis with an FFR angio at 0.74. He also has a short membrane septum (2.5...

TAVI for patients with concomitant coronary artery disease - LIVE case

PCR Tokyo Valves 2024 Welcome Ceremony

17 Feb 2024 – From PCR Tokyo Valves 2024

After a brief overview of the Course's history and the success of the PCR Family's various Courses, join the Course Directors as they unveil the new venue for the 2024 edition, introduce the team, and reveal the schedule for three intense days featuring a diverse and...

PCR Tokyo Valves 2024 Welcome Ceremony

Challenges in TEER for secondary mitral regurgitation

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore this session on secondary mitral regurgitation to understand the ideal case predictors gleaned from trials like EVEREST, COAPT, or MITRA-FR, delve into patient selection conundrums, including optimal medical therapy, examine technical challenges posed by atrial functional mitral regurgitation, and gain insights into TEER techniques for...

Challenges in TEER for secondary mitral regurgitation

Rapid-fire - Complications in SHD interventions

17 Feb 2024 – From PCR Tokyo Valves 2024

Learn more about complications related to structural heart disease interventions through this rapid-fire series of cases. Discover cases such as a cardiac arrest due to coronary artery obstruction two days after TAVI using a balloon-expandable valve, an aortic stenosis case switched to surgery due to severe...

The optimal first valve choice for patients with aortic stenosis - Key considerations for lifetime management

17 Feb 2024 – From PCR Tokyo Valves 2024

This session tackles the pressing topic of TAVI's success in treating aortic stenosis, particularly in younger patients, and the ensuing questions regarding device durability, potential follow-up procedures, and the interplay between TAVI and surgical options. The aim is to ensure optimal decision-making that prioritizes patient welfare...

The optimal first valve

Rapid-fire - Mitral TEER for special situations

17 Feb 2024 – From PCR Tokyo Valves 2024

Gain valuable insights into the possible complications of Mitral Transcatheter Edge-to-Edge Repair (TEER) in the first part of this session rapid-fire submission cases [in Japanese].

Achieving the optimal outcome using the latest self-expandable TAVI - LIVE case

17 Feb 2024 – From PCR Tokyo Valves 2024

An 86-year-old woman presented severe symptomatic aortic stenosis and coronary artery disease with a preserved LV function. The operators performed a PCI of the RCA ostium one month ago. The CT showed a small femoral access (diameter: 5.3 to 4.9 mm). 
After a predilatation with a 20 mm...

Achieving the optimal outcome using the latest self-expandable TAVI - LIVE case

Contemporary techniques for TAV-in-SAV interventions

18 Feb 2024 – From PCR Tokyo Valves 2024

Thanks to this session, take a look at the current outcomes of TAV-in-SAV, analyse the different types of valves and their fracturability, find out more, through case studies, about two different TAV-in-SAV techniques, with or without a stent, and learn how to avoid patient prosthesis mismatch...

Contemporary techniques for TAV-in-SAV interventions

Heart Team in action: managing complex cases together

17 Feb 2024 – From PCR Tokyo Valves 2024

In this group discussion, several heart teams present their work on complex cases of tricuspid valve interventions and explore the results of their collaboration in order to figure out adequate management for invasive treatments. 

Primary mitral regurgitation edge to edge repair with one device - LIVE case

18 Feb 2024 – From PCR Tokyo Valves 2024

An 83-year-old male presented symptomatic severe PMR due to lateral P2 chordal rupture, small LA and preserved LV function (68%). Watch the operators implant one XTW clip successfully.

LIVE case from Sendai Kousei Hospital - Sendai, Japan

 
Navigate the video by moving your mouse over the chapter icon in...

Mitral transcatheter edge to edge repair for a patient with degenerative mitral regurgitation - LIVE case

Shaping the future of structural heart disease intervention

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session if you want to discuss the remaining challenges of transcatheter valvular interventions, and to review latest innovations for structural heart disease.

Shaping the future of structural heart disease intervention

Plan your moves: strategies for valves re-intervention

17 Feb 2024 – From PCR Tokyo Valves 2024

This special session sponsored by Edwards Lifesciences focuses on recognising key elements of valve design that impact ability to host future valves re-interventions, learning how to achieve repeatable implant experiences for the index valve and second valve, and identifying strategies to simplify transcatheter heart valve redo...

Late-Breaking Trial session

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore pivotal findings from registries and studies, including the OCEAN-TAVI Registry on PPM prevalence in Asian TAVR patients, SIL-TAVI Registry insights on TAVI outcomes in cancer patients, the EXPAND G4 study's outcomes for Japanese MitraClip G4 recipients, and TRISTAR study's 30-day results on K-Clip for tricuspid...

Late-Breaking Trial session
Didn’t find what you were looking for?